Logo image of ABCM

ABCAM PLC-SPON ADR (ABCM) Stock Fundamental Analysis

NASDAQ:ABCM - Nasdaq - US0003802040 - ADR - Currency: USD

23.99  +0.01 (+0.04%)

After market: 23.99 0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to ABCM. ABCM was compared to 571 industry peers in the Biotechnology industry. ABCM has an average financial health and profitability rating. ABCM is not priced too expensively while it is growing strongly. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

ABCM had positive earnings in the past year.
In the past year ABCM had a positive cash flow from operations.
ABCM Yearly Net Income VS EBIT VS OCF VS FCFABCM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M

1.2 Ratios

ABCM's Return On Assets of 0.64% is amongst the best of the industry. ABCM outperforms 93.86% of its industry peers.
ABCM has a Return On Equity of 0.93%. This is amongst the best in the industry. ABCM outperforms 93.86% of its industry peers.
Looking at the Return On Invested Capital, with a value of 1.98%, ABCM belongs to the top of the industry, outperforming 94.69% of the companies in the same industry.
ABCM had an Average Return On Invested Capital over the past 3 years of 6.00%. This is significantly below the industry average of 14.16%.
The last Return On Invested Capital (1.98%) for ABCM is well below the 3 year average (6.00%), which needs to be investigated, but indicates that ABCM had better years and this may not be a problem.
Industry RankSector Rank
ROA 0.64%
ROE 0.93%
ROIC 1.98%
ROA(3y)4.53%
ROA(5y)8.06%
ROE(3y)5.58%
ROE(5y)9.64%
ROIC(3y)6%
ROIC(5y)8.74%
ABCM Yearly ROA, ROE, ROICABCM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 5 10 15

1.3 Margins

ABCM's Profit Margin of 1.94% is amongst the best of the industry. ABCM outperforms 94.86% of its industry peers.
In the last couple of years the Profit Margin of ABCM has declined.
ABCM has a better Operating Margin (8.70%) than 95.36% of its industry peers.
In the last couple of years the Operating Margin of ABCM has declined.
ABCM's Gross Margin of 72.69% is amongst the best of the industry. ABCM outperforms 83.58% of its industry peers.
ABCM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.7%
PM (TTM) 1.94%
GM 72.69%
OM growth 3Y-28.84%
OM growth 5Y-15.57%
PM growth 3Y-41.13%
PM growth 5Y-24.24%
GM growth 3Y0.59%
GM growth 5Y0.27%
ABCM Yearly Profit, Operating, Gross MarginsABCM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 20 40 60

More info and screens

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ABCM is destroying value.
ABCM has more shares outstanding than it did 1 year ago.
ABCM has a better debt/assets ratio than last year.
ABCM Yearly Shares OutstandingABCM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M
ABCM Yearly Total Debt VS Total AssetsABCM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 8.64 indicates that ABCM is not in any danger for bankruptcy at the moment.
The Altman-Z score of ABCM (8.64) is better than 85.41% of its industry peers.
ABCM has a debt to FCF ratio of 19.99. This is a negative value and a sign of low solvency as ABCM would need 19.99 years to pay back of all of its debts.
ABCM has a Debt to FCF ratio of 19.99. This is amongst the best in the industry. ABCM outperforms 94.03% of its industry peers.
A Debt/Equity ratio of 0.30 indicates that ABCM is not too dependend on debt financing.
ABCM's Debt to Equity ratio of 0.30 is on the low side compared to the rest of the industry. ABCM is outperformed by 71.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 19.99
Altman-Z 8.64
ROIC/WACC0.22
WACC8.89%
ABCM Yearly LT Debt VS Equity VS FCFABCM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M

2.3 Liquidity

ABCM has a Current Ratio of 1.26. This is a normal value and indicates that ABCM is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ABCM (1.26) is worse than 86.73% of its industry peers.
A Quick Ratio of 0.98 indicates that ABCM may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.98, ABCM is doing worse than 88.56% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.98
ABCM Yearly Current Assets VS Current LiabilitesABCM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 402.64% over the past year.
ABCM shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -17.30% yearly.
ABCM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.70%.
The Revenue has been growing by 11.64% on average over the past years. This is quite good.
EPS 1Y (TTM)402.64%
EPS 3Y-38.1%
EPS 5Y-17.3%
EPS Q2Q%191.67%
Revenue 1Y (TTM)17.7%
Revenue growth 3Y8.48%
Revenue growth 5Y11.64%
Sales Q2Q%23.3%

3.2 Future

The Earnings Per Share is expected to grow by 40.12% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 11.28% on average over the next years. This is quite good.
EPS Next Y125.95%
EPS Next 2Y68.04%
EPS Next 3Y52.49%
EPS Next 5Y40.12%
Revenue Next Year24.37%
Revenue Next 2Y18.92%
Revenue Next 3Y16.75%
Revenue Next 5Y11.28%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ABCM Yearly Revenue VS EstimatesABCM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
ABCM Yearly EPS VS EstimatesABCM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 44.43, which means the current valuation is very expensive for ABCM.
Compared to the rest of the industry, the Price/Earnings ratio of ABCM indicates a rather cheap valuation: ABCM is cheaper than 94.69% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 29.62, ABCM is valued a bit more expensive.
The Price/Forward Earnings ratio is 49.32, which means the current valuation is very expensive for ABCM.
Based on the Price/Forward Earnings ratio, ABCM is valued cheaply inside the industry as 94.53% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.70. ABCM is valued rather expensively when compared to this.
Industry RankSector Rank
PE 44.43
Fwd PE 49.32
ABCM Price Earnings VS Forward Price EarningsABCM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ABCM is valued cheaper than 94.20% of the companies in the same industry.
93.86% of the companies in the same industry are more expensive than ABCM, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 374.67
EV/EBITDA 55.61
ABCM Per share dataABCM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of ABCM may justify a higher PE ratio.
ABCM's earnings are expected to grow with 52.49% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.35
PEG (5Y)N/A
EPS Next 2Y68.04%
EPS Next 3Y52.49%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ABCM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ABCAM PLC-SPON ADR

NASDAQ:ABCM (12/5/2023, 8:00:00 PM)

After market: 23.99 0 (0%)

23.99

+0.01 (+0.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)09-12 2022-09-12/dmh
Earnings (Next)N/A N/A
Inst Owners1.79%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.49B
Analysts80
Price Target20.23 (-15.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 44.43
Fwd PE 49.32
P/S 12.3
P/FCF 374.67
P/OCF 79.64
P/B 5.92
P/tB 42.37
EV/EBITDA 55.61
EPS(TTM)0.54
EY2.25%
EPS(NY)0.49
Fwd EY2.03%
FCF(TTM)0.06
FCFY0.27%
OCF(TTM)0.3
OCFY1.26%
SpS1.95
BVpS4.05
TBVpS0.57
PEG (NY)0.35
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.64%
ROE 0.93%
ROCE 3.54%
ROIC 1.98%
ROICexc 2.23%
ROICexgc 7.95%
OM 8.7%
PM (TTM) 1.94%
GM 72.69%
FCFM 3.28%
ROA(3y)4.53%
ROA(5y)8.06%
ROE(3y)5.58%
ROE(5y)9.64%
ROIC(3y)6%
ROIC(5y)8.74%
ROICexc(3y)7.76%
ROICexc(5y)11.54%
ROICexgc(3y)24.8%
ROICexgc(5y)47.7%
ROCE(3y)9.88%
ROCE(5y)14%
ROICexcg growth 3Y-57.08%
ROICexcg growth 5Y-37.19%
ROICexc growth 3Y-42.21%
ROICexc growth 5Y-23.94%
OM growth 3Y-28.84%
OM growth 5Y-15.57%
PM growth 3Y-41.13%
PM growth 5Y-24.24%
GM growth 3Y0.59%
GM growth 5Y0.27%
F-Score5
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 19.99
Debt/EBITDA 2.79
Cap/Depr 90.64%
Cap/Sales 12.16%
Interest Coverage 9.53
Cash Conversion 69.81%
Profit Quality 169.12%
Current Ratio 1.26
Quick Ratio 0.98
Altman-Z 8.64
F-Score5
WACC8.89%
ROIC/WACC0.22
Cap/Depr(3y)181.11%
Cap/Depr(5y)191.67%
Cap/Sales(3y)16.16%
Cap/Sales(5y)14.67%
Profit Quality(3y)125.12%
Profit Quality(5y)105.69%
High Growth Momentum
Growth
EPS 1Y (TTM)402.64%
EPS 3Y-38.1%
EPS 5Y-17.3%
EPS Q2Q%191.67%
EPS Next Y125.95%
EPS Next 2Y68.04%
EPS Next 3Y52.49%
EPS Next 5Y40.12%
Revenue 1Y (TTM)17.7%
Revenue growth 3Y8.48%
Revenue growth 5Y11.64%
Sales Q2Q%23.3%
Revenue Next Year24.37%
Revenue Next 2Y18.92%
Revenue Next 3Y16.75%
Revenue Next 5Y11.28%
EBIT growth 1Y-18.45%
EBIT growth 3Y-22.8%
EBIT growth 5Y-5.74%
EBIT Next Year197.84%
EBIT Next 3Y63.16%
EBIT Next 5Y39.34%
FCF growth 1Y-42.5%
FCF growth 3Y-17.2%
FCF growth 5Y-14.26%
OCF growth 1Y66.98%
OCF growth 3Y4.34%
OCF growth 5Y8.73%